Cargando…

Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”

Male infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases....

Descripción completa

Detalles Bibliográficos
Autores principales: Symeonidis, Evangelos N., Evgeni, Evangelini, Palapelas, Vasileios, Koumasi, Dimitra, Pyrgidis, Nikolaos, Sokolakis, Ioannis, Hatzichristodoulou, Georgios, Tsiampali, Chara, Mykoniatis, Ioannis, Zachariou, Athanasios, Sofikitis, Nikolaos, Kaltsas, Ares, Dimitriadis, Fotios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533291/
https://www.ncbi.nlm.nih.gov/pubmed/34679669
http://dx.doi.org/10.3390/antiox10101534
_version_ 1784587277432782848
author Symeonidis, Evangelos N.
Evgeni, Evangelini
Palapelas, Vasileios
Koumasi, Dimitra
Pyrgidis, Nikolaos
Sokolakis, Ioannis
Hatzichristodoulou, Georgios
Tsiampali, Chara
Mykoniatis, Ioannis
Zachariou, Athanasios
Sofikitis, Nikolaos
Kaltsas, Ares
Dimitriadis, Fotios
author_facet Symeonidis, Evangelos N.
Evgeni, Evangelini
Palapelas, Vasileios
Koumasi, Dimitra
Pyrgidis, Nikolaos
Sokolakis, Ioannis
Hatzichristodoulou, Georgios
Tsiampali, Chara
Mykoniatis, Ioannis
Zachariou, Athanasios
Sofikitis, Nikolaos
Kaltsas, Ares
Dimitriadis, Fotios
author_sort Symeonidis, Evangelos N.
collection PubMed
description Male infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases. Nowadays, urologists are confronted with a wide spectrum of conditions ranging from the typical infertile male to more complex cases of either unexplained or idiopathic male infertility, requiring a specific patient-tailored diagnostic approach and management. Strikingly enough, no identifiable cause in routine workup can be found in 30% to 50% of infertile males. The medical term male oxidative stress infertility (MOSI) was recently coined to describe infertile men with abnormal sperm parameters and oxidative stress (OS), including those previously classified as having idiopathic infertility. OS is a critical component of male infertility, entailing an imbalance between reactive oxygen species (ROS) and antioxidants. ROS abundance has been implicated in sperm abnormalities, while the exact impact on fertilization and pregnancy has long been a subject of considerable debate. In an attempt to counteract the deleterious effects of OS, urologists resorted to antioxidant supplementation. Mounting evidence indicates that indiscriminate consumption of antioxidants has led in some cases to sperm cell damage through a reductive-stress-induced state. The “antioxidant paradox”, one of the biggest andrological challenges, remains a lurking danger that needs to be carefully avoided and thoroughly investigated. For that reason, oxidation-reduction potential (ORP) emerged as a viable ancillary tool to basic semen analysis, measuring the overall balance between oxidants and antioxidants (reductants). A novel biomarker, the Male infertility Oxidative System (MiOXSYS(®)), is a paradigm shift towards that goal, offering a quantification of OS via a quick, reliable, and reproducible measurement of the ORP. Moderation or “Μέτρον” according to the ancient Greeks is the key to successfully safeguarding redox balance, with MiOXSYS(®) earnestly claiming its position as a guarantor of homeostasis in the intracellular redox milieu. In the present paper, we aim to offer a narrative summary of evidence relevant to redox regulation in male reproduction, analyze the impact of OS and reductive stress on sperm function, and shed light on the “antioxidant paradox” phenomenon. Finally, we examine the most up-to-date scientific literature regarding ORP and its measurement by the recently developed MiOXSYS(®) assay.
format Online
Article
Text
id pubmed-8533291
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85332912021-10-23 Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον” Symeonidis, Evangelos N. Evgeni, Evangelini Palapelas, Vasileios Koumasi, Dimitra Pyrgidis, Nikolaos Sokolakis, Ioannis Hatzichristodoulou, Georgios Tsiampali, Chara Mykoniatis, Ioannis Zachariou, Athanasios Sofikitis, Nikolaos Kaltsas, Ares Dimitriadis, Fotios Antioxidants (Basel) Review Male infertility, a relatively common and multifactorial medical condition, affects approximately 15% of couples globally. Based on WHO estimates, a staggering 190 million people struggle with this health condition, and male factor is the sole or contributing factor in roughly 20–50% of these cases. Nowadays, urologists are confronted with a wide spectrum of conditions ranging from the typical infertile male to more complex cases of either unexplained or idiopathic male infertility, requiring a specific patient-tailored diagnostic approach and management. Strikingly enough, no identifiable cause in routine workup can be found in 30% to 50% of infertile males. The medical term male oxidative stress infertility (MOSI) was recently coined to describe infertile men with abnormal sperm parameters and oxidative stress (OS), including those previously classified as having idiopathic infertility. OS is a critical component of male infertility, entailing an imbalance between reactive oxygen species (ROS) and antioxidants. ROS abundance has been implicated in sperm abnormalities, while the exact impact on fertilization and pregnancy has long been a subject of considerable debate. In an attempt to counteract the deleterious effects of OS, urologists resorted to antioxidant supplementation. Mounting evidence indicates that indiscriminate consumption of antioxidants has led in some cases to sperm cell damage through a reductive-stress-induced state. The “antioxidant paradox”, one of the biggest andrological challenges, remains a lurking danger that needs to be carefully avoided and thoroughly investigated. For that reason, oxidation-reduction potential (ORP) emerged as a viable ancillary tool to basic semen analysis, measuring the overall balance between oxidants and antioxidants (reductants). A novel biomarker, the Male infertility Oxidative System (MiOXSYS(®)), is a paradigm shift towards that goal, offering a quantification of OS via a quick, reliable, and reproducible measurement of the ORP. Moderation or “Μέτρον” according to the ancient Greeks is the key to successfully safeguarding redox balance, with MiOXSYS(®) earnestly claiming its position as a guarantor of homeostasis in the intracellular redox milieu. In the present paper, we aim to offer a narrative summary of evidence relevant to redox regulation in male reproduction, analyze the impact of OS and reductive stress on sperm function, and shed light on the “antioxidant paradox” phenomenon. Finally, we examine the most up-to-date scientific literature regarding ORP and its measurement by the recently developed MiOXSYS(®) assay. MDPI 2021-09-27 /pmc/articles/PMC8533291/ /pubmed/34679669 http://dx.doi.org/10.3390/antiox10101534 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Symeonidis, Evangelos N.
Evgeni, Evangelini
Palapelas, Vasileios
Koumasi, Dimitra
Pyrgidis, Nikolaos
Sokolakis, Ioannis
Hatzichristodoulou, Georgios
Tsiampali, Chara
Mykoniatis, Ioannis
Zachariou, Athanasios
Sofikitis, Nikolaos
Kaltsas, Ares
Dimitriadis, Fotios
Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_full Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_fullStr Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_full_unstemmed Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_short Redox Balance in Male Infertility: Excellence through Moderation—“Μέτρον ἄριστον”
title_sort redox balance in male infertility: excellence through moderation—“μέτρον ἄριστον”
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533291/
https://www.ncbi.nlm.nih.gov/pubmed/34679669
http://dx.doi.org/10.3390/antiox10101534
work_keys_str_mv AT symeonidisevangelosn redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT evgenievangelini redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT palapelasvasileios redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT koumasidimitra redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT pyrgidisnikolaos redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT sokolakisioannis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT hatzichristodoulougeorgios redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT tsiampalichara redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT mykoniatisioannis redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT zachariouathanasios redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT sofikitisnikolaos redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT kaltsasares redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston
AT dimitriadisfotios redoxbalanceinmaleinfertilityexcellencethroughmoderationmetronariston